A detailed history of Baillie Gifford & CO transactions in Inspire Medical Systems, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 1,426,835 shares of INSP stock, worth $278 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,426,835
Previous 1,467,613 2.78%
Holding current value
$278 Million
Previous $315 Million 39.42%
% of portfolio
0.15%
Previous 0.25%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$133.83 - $251.19 $5.46 Million - $10.2 Million
-40,778 Reduced 2.78%
1,426,835 $191 Million
Q1 2024

May 01, 2024

BUY
$165.3 - $226.0 $39.3 Million - $53.7 Million
237,734 Added 19.33%
1,467,613 $315 Million
Q4 2023

Jan 26, 2024

BUY
$125.26 - $203.83 $152 Million - $247 Million
1,212,175 Added 6846.9%
1,229,879 $250 Million
Q3 2023

Nov 13, 2023

BUY
$185.0 - $326.08 $1.83 Million - $3.22 Million
9,875 Added 126.13%
17,704 $3.51 Million
Q2 2023

Jul 28, 2023

BUY
$226.52 - $324.64 $1.73 Million - $2.48 Million
7,644 Added 4131.89%
7,829 $2.54 Million
Q1 2023

May 03, 2023

BUY
$229.06 - $278.01 $5,268 - $6,394
23 Added 14.2%
185 $43,000
Q3 2022

Oct 27, 2022

SELL
$170.68 - $226.46 $1,877 - $2,491
-11 Reduced 6.36%
162 $29,000
Q2 2022

Aug 08, 2022

BUY
$147.53 - $266.6 $2,803 - $5,065
19 Added 12.34%
173 $32,000
Q4 2021

Jan 20, 2022

SELL
$207.57 - $280.17 $3,321 - $4,482
-16 Reduced 9.41%
154 $35,000
Q3 2021

Oct 19, 2021

SELL
$170.0 - $258.58 $4,760 - $7,240
-28 Reduced 14.14%
170 $40,000
Q2 2021

Aug 02, 2021

SELL
$164.93 - $242.23 $1,649 - $2,422
-10 Reduced 4.81%
198 $38,000
Q1 2021

May 06, 2021

BUY
$182.45 - $249.25 $2,189 - $2,991
12 Added 6.12%
208 $43,000
Q4 2020

Feb 10, 2021

BUY
$119.35 - $200.46 $23,392 - $39,290
196 New
196 $37,000

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $5.61B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.